Stay updated on Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The site’s footer revision label changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T22:31:58.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:25:46.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the previous study details and document links. This indicates the record is currently inaccessible due to access restrictions.
    Difference
    19%
    Check dated 2026-09-20T20:40:20.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6. This reflects a small site update that changes the page version label but does not alter the study details or their presentation.
    Difference
    0.1%
    Check dated 2026-08-30T22:37:47.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.4 to v3.6.5, indicating a new version of the page.
    Difference
    0.1%
    Check dated 2026-08-09T11:36:11.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.3 to v3.6.4, indicating a recent build or deployment of the page.
    Difference
    0.1%
    Check dated 2026-07-25T23:29:23.000Z thumbnail image

Stay in the know with updates to Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial page.